Showing results 1 to 20 of 48
next >
| Issue Date | Title | Author(s) |
| 2022-06-16 | The FACT-8D, a new cancer-specific utility algorithm based on the Functional Assessment of Cancer Therapies-General (FACT-G): a Canadian valuation study. | McTaggart-Cowan, H; King, MT; Norman, R; Costa, DSJ; Pickard, AS; Viney, R; Peacock, SJ; Canadian MAUCa Team, |
| 2021-06-01 | The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set | King, MT; Norman, R; Mercieca-Bebber, R; Costa, DSJ; McTaggart-Cowan, H; Peacock, S; Janda, M; Muller, F; Viney, R; Pickard, AS; Cella, D |
| 2021-06 | The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set. | King, MT; Norman, R; Mercieca-Bebber, R; Costa, DSJ; McTaggart-Cowan, H; Peacock, S; Janda, M; Müller, F; Viney, R; Pickard, AS; Cella, D; Multi-Attribute Utility in Cancer Consortium, |
| 2021-05 | United States Utility Algorithm for the EORTC QLU-C10D, a Multiattribute Utility Instrument Based on a Cancer-Specific Quality-of-Life Instrument. | Revicki, DA; King, MT; Viney, R; Pickard, AS; Mercieca-Bebber, R; Shaw, JW; Müller, F; Norman, R |
| 2020-01 | Assessing quality of life in palliative care settings: head-to-head comparison of four patient-reported outcome measures (EORTC QLQ-C15-PAL, FACT-Pal, FACT-Pal-14, FACT-G7). | King, MT; Agar, M; Currow, DC; Hardy, J; Fazekas, B; McCaffrey, N |
| 2019-01 | The EORTC QLU-C10D: The Canadian Valuation Study and Algorithm to Derive Cancer-Specific Utilities From the EORTC QLQ-C30. | McTaggart-Cowan, H; King, MT; Norman, R; Costa, DSJ; Pickard, AS; Regier, DA; Viney, R; Peacock, SJ |
| 2019 | Developing UK values for cancer health states | Norman, R; Mercieca-Bebber, R; Brazier, JE; Cella, D; Pickard, AS; Rowen, D; Street, D; Viney, R; King, MT |
| 2019 | U.K. utility weights for the EORTC QLU‐C10D | Norman, R; Mercieca-Bebber, R; Rowen, D; Brazier, JE; Cella, D; Pickard, AS; Street, DJ; Viney, R; King, MT |
| 2018-05-01 | Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial | Porceddu, SV; Bressel, M; Poulsen, MG; Stoneley, A; Veness, MJ; Kenny, LM; Wratten, C; Corry, J; Cooper, S; Fogarty, GB; Collins, M; Collins, MK; Macann, AMJ; Milross, CG; Penniment, MG; Liu, HYH; King, MT; Panizza, BJ; Rischin, D |
| 2018-02-01 | Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30 | King, MT; Viney, R; Simon Pickard, A; Rowen, D; Aaronson, NK; Brazier, JE; Cella, D; Costa, DSJ; Fayers, PM; Kemmler, G; McTaggart-Cowen, H; Mercieca-Bebber, R; Peacock, S; Street, DJ; Young, TA; Norman, R; Aaronson, N; Brazier, J; Costa, D; Fayers, P; Grimison, P; Janda, M; King (Chair), M; McTaggart-Cowan, H; Pickard, S; Velikova, G; Street, D; Young, T |
| 2017-08-01 | Erratum to: Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format (Quality of Life Research, (2016), 25, 3, (637-649), 10.1007/s11136-015-1115-3) | Norman, R; Viney, R; Aaronson, NK; Brazier, JE; Cella, D; Costa, DSJ; Fayers, PM; Kemmler, G; Peacock, S; Pickard, AS; Rowen, D; Street, DJ; Velikova, G; Young, TA; King, MT |
| 2016-04-01 | The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study | Smith, AB; Butow, P; Olver, I; Luckett, T; Grimison, P; Toner, GC; Stockler, MR; Hovey, E; Stubbs, J; Turner, S; Hruby, G; Gurney, H; Alam, M; Cox, K; King, MT |
| 2016-03-01 | Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format | Norman, R; Viney, R; Aaronson, NK; Brazier, JE; Cella, D; Costa, DSJ; Fayers, PM; Kemmler, G; Peacock, S; Pickard, AS; Rowen, D; Street, DJ; Velikova, G; Young, TA; King, MT |
| 2014-01-01 | An Australian discrete choice experiment to value EQ-5D health states | Viney, R; Norman, R; Brazier, J; Cronin, P; King, MT; Ratcliffe, J; Street, D |
| 2014-01-01 | PerCEN: A cluster randomized controlled trial of person-centered residential care and environment for people with dementia | Chenoweth, L; Forbes, I; Fleming, R; King, MT; Stein-Parbury, J; Luscombe, G; Kenny, P; Jeon, YH; Haas, M; Brodaty, H |
| 2014-01-01 | Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approach | Costa, DSJ; Aaronson, NK; Fayers, PM; Grimison, PS; Janda, M; Pallant, JF; Rowen, D; Velikova, G; Viney, R; Young, TA; King, MT |
| 2012-12-01 | Repeatability of the six-minute walk test and relation to physical function in survivors of a critical illness | Alison, JA; Kenny, P; King, MT; Mckinley, S; Aitken, LM; Leslie, GD; Elliott, D |
| 2012-06-01 | A comparison of the FACT-G and the Supportive Care Needs Survey (SCNS) in women with ovarian cancer: Unidimensionality of constructs | Colagiuri, B; King, MT; Butow, PN; McGrane, JA; Luckett, T; Price, MA; Birney, DP |
| 2012-02-14 | Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer | King, MT; Viney, R; Smith, DP; Hossain, I; Street, D; Savage, E; Fowler, S; Berry, MP; Stockler, M; Cozzi, P; Stricker, P; Ward, J; Armstrong, BK |
| 2011-12-01 | Psychological morbidity and quality of life of ethnic minority patients with cancer: A systematic review and meta-analysis | Luckett, T; Goldstein, D; Butow, PN; Gebski, V; Aldridge, LJ; McGrane, J; Ng, W; King, MT |
